Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Ossy

5 clinical trials in Ossy, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Ossy at a glance
5
clinical trials
  • Recruiting now0
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Ossy

Open in trial search
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Almirall S.A.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Spesolimab
  • Sponsor:Boehringer Ingelheim Espana S.A.

Hidradenitis

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Humanised Igg4 Kappa Monoclonal Antibody Against Cxcl1, Cxcl2, Cxcl3, Cxcl5, Cxcl6, Cxcl7 And Cxcl8
  • Sponsor:Eli Lilly & Co.

Hidradenitis

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Spesolimab
  • Sponsor:Boehringer Ingelheim Espana S.A.

Dermatitis atopic

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bp1.7881A
  • Sponsor:Bioprojet Pharma

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Ossy

What the registry says about research in the country

01 Dermatological Research

Clinical trials focusing on hidradenitis suppurativa (HS), investigating the long-term effectiveness and safety of novel therapeutic approaches. Research includes evaluating treatment responses in patients with moderate to severe conditions.

  • Spesolimab Studies
  • Long-term Safety Assessments
  • Treatment Optimization

Multiple phases of research aim to determine optimal dosing strategies and confirm treatment efficacy.

02 Atopic Dermatitis Investigations

Comprehensive research into moderate-to-severe atopic dermatitis treatments, including studies of oral medications and innovative biological therapies. These trials aim to expand treatment options for patients.

  • BP1.7881 Clinical Evaluation
  • Lebrikizumab Studies
  • Long-term Safety Monitoring

Extended observation periods of up to 2 years ensure thorough assessment of treatment outcomes.

03 Therapeutic Innovation

Advanced clinical research exploring novel treatment approaches for chronic skin conditions. Studies incorporate both adult and adolescent patient populations to ensure comprehensive therapeutic development.

  • Drug Safety Profiles
  • Treatment Efficacy
  • Patient Response Monitoring

Research protocols include randomized, double-blind, placebo-controlled methodologies to ensure robust results.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.